Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Aggarwal

Showing results (171-180 of 262) with videos related to

Pageof 27
Sort By:
Rheumatology and Therapy|July 5, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM StudyRohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Rheumatology (Oxford, England)|April 25, 2025
Short Form-36 psychometric properties in idiopathic inflammatory myopathies: reliability, validity, and responsivenessShiri Keret, Anushka Aggarwal, Maha Almackenzie, et al.
Scientific Reports|December 22, 2025
Sit to stand and timed up and go in idiopathic inflammatory myopathiesTanya Chandra, Raisa L Silva, Shiri Keret, et al.
The Journal of Rheumatology|April 3, 2018
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case ReviewTracy J Doyle, Namrata Dhillon, Rachna Madan, et al.
Arthritis Research & Therapy|January 17, 2024
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM studyRohit Aggarwal, Joachim Schessl, Christina Charles-Schoeman, et al.
Rheumatology International|June 6, 2022
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based reviewDaniel Gonzalez, Latika Gupta, Vijaya Murthy, et al.
Rheumatology (Oxford, England)|December 7, 2021
Assessment of disability in idiopathic inflammatory myopathy: a call for linearityMinoesch Min, Anne W Walter, Johan Lim, et al.
Rheumatology (Oxford, England)|April 23, 2025
Recruitment rate comparison between a virtual tele-research cohort and a traditional center-based cohort in idiopathic inflammatory myopathySiamak Moghadam-Kia, Anushka Aggarwal, Swamy Venuturupalli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositisRohit Aggarwal, Andriy Bandos, Ann M Reed, et al.
The Journal of Rheumatology|October 1, 2025
Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-Based ApproachNantakarn Pongtarakulpanit, Anuradha Bishnoi, Tanya Chandra, et al.
Pageof 27

Showing results (171-180 of 262) with videos related to

Sort By:
Pageof 27
Rheumatology and Therapy|July 5, 2025
Efficacy of Intravenous Immunoglobulin for Systemic Manifestations of Dermatomyositis Beyond Muscular and Cutaneous: Sub-analysis of the ProDERM StudyRohit Aggarwal, Joachim Schessl, Zsuzsanna Bata-Csörgő, et al.
Rheumatology (Oxford, England)|April 25, 2025
Short Form-36 psychometric properties in idiopathic inflammatory myopathies: reliability, validity, and responsivenessShiri Keret, Anushka Aggarwal, Maha Almackenzie, et al.
Scientific Reports|December 22, 2025
Sit to stand and timed up and go in idiopathic inflammatory myopathiesTanya Chandra, Raisa L Silva, Shiri Keret, et al.
The Journal of Rheumatology|April 3, 2018
Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case ReviewTracy J Doyle, Namrata Dhillon, Rachna Madan, et al.
Arthritis Research & Therapy|January 17, 2024
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM studyRohit Aggarwal, Joachim Schessl, Christina Charles-Schoeman, et al.
Rheumatology International|June 6, 2022
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based reviewDaniel Gonzalez, Latika Gupta, Vijaya Murthy, et al.
Rheumatology (Oxford, England)|December 7, 2021
Assessment of disability in idiopathic inflammatory myopathy: a call for linearityMinoesch Min, Anne W Walter, Johan Lim, et al.
Rheumatology (Oxford, England)|April 23, 2025
Recruitment rate comparison between a virtual tele-research cohort and a traditional center-based cohort in idiopathic inflammatory myopathySiamak Moghadam-Kia, Anushka Aggarwal, Swamy Venuturupalli, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2014
Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositisRohit Aggarwal, Andriy Bandos, Ann M Reed, et al.
The Journal of Rheumatology|October 1, 2025
Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-Based ApproachNantakarn Pongtarakulpanit, Anuradha Bishnoi, Tanya Chandra, et al.
Pageof 27